Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. As the biopharmaceutical market grows, so should interest in the cell culture products market. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. As growing cells for biopharmaceutical production is slow, […]
May 1, 2009
The multi-billion veterinary health products market, though smaller in opportunity as compared with the human health sector, offers significant return on investment, primarily driven by lower risk and faster product development cycles. The veterinary health products market has remained resilient over the economic downturns of the past 2 decades. This report, World Veterinary Health Products, […]
May 1, 2009
The pharmaceutical market in India ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be essential for pharmaceutical companies exploring new opportunities for growth. Developing regions will be an integral part of expansion for companies looking to capture a larger portion of […]
April 1, 2009
Pharmacodiagnostics are considered the pathway to what has been termed “personalized medicine,” the use of molecular analysis to achieve optimum medical outcomes in the management of a patient’s disease or predisposition to disease. As such, personalized medicine promises to bring about a new standard of healthcare, with the possiblity to increase profits, speed clinical trials, […]
April 1, 2009
Current economic conditions dominate business strategies. While healthcare has fared better than other industries, it will not be immune from the effects of the current recession. But what aspects of healthcare will be impacted? How much of spending will be out of the consumer’s pocket? How will some novel trends (retail clinics, medical tourism) fit […]
April 1, 2009
Wound care is a constantly changing market. New wound care products and devices are entering the market with quickly to treat the most painful and critical of injuries, all striving for the best clinical outcomes. Kalorama’s Wound Care Markets, 4th Edition, Vol. II: Burns represents the fourth time that Kalorama has rexamined this aspect of […]
April 1, 2009
The dialysis industry enjoys a unique place in the healthcare sector. The industry encompasses two very lucrative segments — the medical device industry (dialysis products and supplies segment) and the healthcare services industry (dialysis services segment). The dialysis industry remains a robust, multi-billion business that has managed to fuel its growth engine in the past […]
April 1, 2009
From Kalorama Information a unique tool for assessing the diagnostic business today. Working in conjunction with premier diagnostic survey database Emmes Group, Kalorama Information presents the summarized results from a recent survey of a critical mass of diagnostic labs in the U.S, with analysis from Kalorama’s leading diagnostic analyst, Shara Rosen. Far more than any […]
April 1, 2009
Wound care is a constantly changing market. The trend toward cost-effective skin ulcer treatment remains embedded in management programs that emphasize prevention and early intervention. New wound care products and devices are entering the market with lightening speed, all striving for the best clinical outcomes. Kalorama’s Wound Care Markets, 4th Edition, Vol. I: Skin Ulcers. […]
March 1, 2009
The appearance of in-store health clinics is a significant trend for pharmaceutical and POC diagnostic market watchers, as well as for those in retail. When last Kalorama published the first syndicated market research study on the emerging trend of in-store clinics in 2007, retail clinics were a novel trend. Now, with a few years of […]
March 1, 2009